Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain

This work was supported by the Stavros Niarchos Foundation, Banco Santander, and other private donors through the Kids Corona Platform (Institut de Recerca Sant Joan de Deu), and the Fundació Privada Daniel Bravo Andreu. G.M. was supported by the Departament de Salut, Generalitat de Catalunya (grant...

Descripción completa

Detalles Bibliográficos
Autores: Dobaño, Carlota, Alonso, Selena, Fernández de Sevilla, Mariona, Vidal, Marta, Jiménez, Alfons, Pons Tomas, Gemma, Jairoce, Chenjerai, Melé Casas, María, Rubio, Rocío, Hernández García, María, Ruiz-Olalla, Gemma, Girona-Alarcón, Mònica, Barrios, Diana, Santano, Rebeca, Mitchell, Robert A., Puyol, Laura, Mayer, Leonie, Chi, Jordi, Rodrigo Melero, Natalia, Carolis, Carlo, Garcia-Miquel, Aleix, Bonet-Carne, Elisenda, Claverol, Joana, Cubells, Marta, Fortuny, Claudia, Fumado, Vicky, Jou, Cristina, Muñoz-Almagro, Carmen, Izquierdo, Luis, Bassat, Quique, Gratacós, Eduard, Aguilar, Ruth, García-García, Juan José, Moncunill, Gemma, Jordan, Iolanda
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:20.500.12328/3016
Acceso en línea:http://hdl.handle.net/20.500.12328/3016
https://dx.doi.org/10.1186/s12916-021-02184-1
Access Level:acceso abierto
Palabra clave:SARS-CoV-2
Conversió d'anticossos
Saliva
Nens
Escoles
Conversión de anticuerpos
Niños
Escuelas
Antibody conversion
Children
Schools
578
61
616.9
Descripción
Sumario:This work was supported by the Stavros Niarchos Foundation, Banco Santander, and other private donors through the Kids Corona Platform (Institut de Recerca Sant Joan de Deu), and the Fundació Privada Daniel Bravo Andreu. G.M. was supported by the Departament de Salut, Generalitat de Catalunya (grant number SLT006/17/00109). L.I. work was supported by PID2019-110810RB-I00 grant from the Spanish Ministry of Science & Innovation. Development of SARS-CoV-2 reagents was partially supported by the National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Surveillance (contract number HHSN272201400008C). ISGlobal receives support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019-2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program.

Similares en LA Referencia